Notably, the co-treatment of Caki-1 xenograft mice with 5-aza-2′-deoxycytidine and VBL led not only to suppression of tumor volume and weight but also reduced the expression of P-gp, Bcl-2 and cyclin B1. Here, BCL2 is linked to neoplasm.